HMGB1 and central nervous system cancer: Taken together, these data support that, similar to IL-1α and HMGB1 (ref. 71), IL-33 has a dual function in glioma by acting as both a pro-inflammatory cytokine and an intracellular nuclear factor, functions required to drive glioma progression.